Although a study in mice demonstrated that depletion of FAPα+ cells can result in cachexia and anemia and FAPα+ cells were found to reside in most tissues, including muscle and bone marrow [46], studies investigating the potential use of FAPα as a therapeutic target in diseases are ongoing. The gene discussed is FAP; the disease is Cachexia.